Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury
Journal
Journal of clinical medicine
Journal Volume
7
Journal Issue
9
Date Issued
2018-08-29
Author(s)
Shiao, Chih-Chung
Kan, Wei-Chih
Wang, Jian-Jhong
Chen, Likwang
Chueh, Eric
Huang, Ya-Ting
Chiang, Wen-Po
Tseng, Li-Jung
Abstract
The influence of acute kidney injury (AKI) on subsequent incident atrial fibrillation (AF) has not yet been fully addressed. This retrospective nationwide cohort study was conducted using Taiwan's National Health Insurance Research Database from 1 January 2000 to 31 December 2010. A total of 41,463 patients without a previous AF, mitral valve disease, and hyperthyroidism who developed de novo dialysis-requiring AKI (AKI-D) during their index hospitalization were enrolled. After propensity score matching, "non-recovery group" (n = 2895), "AKI-recovery group" (n = 2895) and "non-AKI group" (control group, n = 5790) were categorized. Within a follow-up period of 6.52 ± 3.88 years (median, 6.87 years), we found that the adjusted risks for subsequent incident AF were increased in both AKI-recovery group (adjusted hazard ratio (aHR) = 1.30; 95% confidence intervals (CI), 1.07⁻1.58; p ≤ 0.01) and non-recovery group (aHR = 1.62; 95% CI, 1.36⁻1.94) compared to the non-AKI group. Furthermore, the development of AF carried elevated risks for major adverse cardiac events (aHR = 2.11; 95% CI, 1.83⁻2.43), ischemic stroke (aHR = 1.33; 95% CI, 1.19⁻1.49), and all stroke (aHR = 1.28; 95% CI, 1.15⁻1.43). (all p ≤ 0.001, except otherwise expressed) The authors concluded that AKI-D, even in those who withdrew from temporary dialysis, independently increases the subsequent risk of de novo AF.
Subjects
acute kidney injury; adverse cardiovascular events; atrial fibrillation; dialysis
Acute kidney injury; Adverse cardiovascular events; Atrial fibrillation; Dialysis
SDGs
Other Subjects
acetylsalicylic acid; antidiabetic agent; calcium channel blocking agent; clopidogrel; dipyridamole; diuretic agent; hydroxymethylglutaryl coenzyme A reductase inhibitor; nitrate; ticlopidine; acute kidney failure; adult; aged; Article; atrial fibrillation; brain ischemia; cerebrovascular accident; CHA2DS2-VASc score; Charlson Comorbidity Index; chronic kidney failure; chronic obstructive lung disease; cohort analysis; end stage renal disease; female; human; ICD-9-CM; major adverse cardiac event; major clinical study; male; mortality; propensity score; retrospective study; risk factor
Publisher
MDPI
Type
journal article